The National Institute of Mental Health (NIMH) awarded a $1,111,187 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Georgetown University to investigate the functional role of the chromatin remodeling protein CHD1 in regulating synaptic homeostatic plasticity. The 5-year grant, which runs from July 2024 to January 2029, aims to elucidate how CHD1-controlled signaling pathways are integrated within synaptic homeostatic mechanisms and how human disease variants in the related CHD2 gene impact synaptic physiology. The research will employ a multifaceted approach, including genetic tools, electrophysiology, super-resolution imaging, transcriptomics, and computational analyses, to systematically map the CHD1-dependent signaling network that stabilizes synaptic function. The findings could provide critical insights into the molecular and cellular mechanisms underlying autism spectrum disorder, epilepsy, and intellectual disability.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $332.0k | 1/17/25 | ||
| Not listed | $389.6k | 7/15/24 | ||
| Not listed | $389.6k | 7/15/24 |